David Lebwohl
2021
In 2021, David Lebwohl earned a total compensation of $4.3M as Executive Vice President, Chief Medical Officer at Intellia Therapeutics, a 105% increase compared to previous year.
Compensation breakdown
| Bonus | $269,480 |
|---|---|
| Option Awards | $2,792,916 |
| Salary | $458,300 |
| Stock Awards | $735,803 |
| Other | $9,060 |
| Total | $4,265,559 |
Lebwohl received $2.8M in option awards, accounting for 65% of the total pay in 2021.
Lebwohl also received $269.5K in bonus, $458.3K in salary, $735.8K in stock awards and $9.1K in other compensation.
Rankings
In 2021, David Lebwohl's compensation ranked 3,117th out of 12,397 executives tracked by ExecPay. In other words, Lebwohl earned more than 74.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,117 out of 12,397 | 75th |
Division Manufacturing | 1,251 out of 5,492 | 77th |
Major group Chemicals And Allied Products | 505 out of 2,367 | 79th |
Industry group Drugs | 447 out of 2,090 | 79th |
Industry In Vitro and In Vivo Diagnostic Substances | 8 out of 61 | 87th |
Source: SEC filing on May 2, 2022.
Lebwohl's colleagues
We found four more compensation records of executives who worked with David Lebwohl at Intellia Therapeutics in 2021.